Pandemic Latest News

Zepbound

Eli Lilly announces direct-to-patient portal for new weight loss drug; The latest health stories from around the world

Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi Eli Lilly, maker of the anti-obesity drug Zepbound, announced last week the launch of LillyDirect, a direct-to-patient portal, allowing some patients to obtain its drug for as little as $25 a month.  The move is seen as a major shift in the way …

Eli Lilly announces direct-to-patient portal for new weight loss drug; The latest health stories from around the world Read More »

UK approves CRISPR gene therapy for SCD; The latest health stories from around the world

Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi  In a world first, U.K. regulators have approved a therapy that uses CRISPR, the Nobel Prize–winning gene-editing tool invented in 2012. The treatment has been shown to help people with beta thalassemia and sickle cell disease, both inherited blood disorders that …

UK approves CRISPR gene therapy for SCD; The latest health stories from around the world Read More »